Ustekinumab Market – Expanding in Psoriasis and IBD

added blog Health

2026-09-17 13:18:39 -

Market OverviewThe ustekinumab market is accelerating as psoriasis and inflammatory bowel disease (IBD) demand grows. Ustekinumab targets IL-12/23 and treats plaque psoriasis, psoriatic arthritis, Crohn’s, and ulcerative colitis. The market is projected to grow through 2030, driven by biologics adoption, biosimilar entry, and emerging markets. Growing adoption of the Ustekinumab Market...

0 Comments 0 Shares 34 Views 0 Reviews